Pharmaceutical News

RSS

Studies support clinical use of antidepressants for treatment of postoperative pain

Antidepressants are known to provide effective pain relief for various chronic pain conditions; however, the jury is still out on their use in treating the millions of patients who suffer from acute or chronic pain following surgery.

20 Aug 2014

Perampanel does not offer added benefit for patients with Epilepsy

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures).

20 Aug 2014

New therapeutic drug may prevent respiratory depression in patients taking opioid medication

People taking prescription opioids to treat moderate to severe pain may be able to breathe a little easier, literally.

20 Aug 2014

Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

A leukemia drug called dasatinib shows promise for treating skin, breast and several other cancers, according to researchers at Loyola University Chicago Stritch School of Medicine.

20 Aug 2014

Researchers shed light on the dual action of aspirin

Hugely popular non-steroidal anti-inflammation drugs like aspirin, naproxen (marketed as Aleve) and ibuprofen (Advil, Motrin) all work by inhibiting or killing an enzyme called cyclooxygenase - a key catalyst in production of hormone-like lipid compounds called prostaglandins that are linked to a variety of ailments, from headaches and arthritis to menstrual cramps and wound sepsis.

19 Aug 2014

Acetyl fentanyl is more potent and dangerous than heroin

Emergency physicians should expect "an upswing in what on the surface appear to be heroin overdoses," but are actually overdoses tied to acetyl fentanyl, an opiate that is mixed into street drugs marketed as heroin.

19 Aug 2014

University of Kansas researcher earns grant to study role of dietary supplement in muscle growth

A University of Kansas professor has been chosen to take part in a grant project that will test the role of a dietary supplement in muscle growth for everyone from athletes to the elderly and has also been named educator of the year by the granting agency.

19 Aug 2014

Novartis and Gamida Cell sign Option and Investment Agreements

Elbit Imaging Ltd. announced today that Elbit Medical Technologies Ltd., a subsidiary of the Company in which it holds approximately 86% of the voting power, announced that on August 18, 2014, Gamida Cell Ltd., in which Elbit Medical holds approximately 30.8% of the voting power and a vast majority of Gamida Cell's shareholders (including Elbit Medical), signed Option and Investment Agreements with Novartis Pharma AG (Novartis).

19 Aug 2014

New research finds that early use of antibiotics can alter immunity later on

New University of British Columbia research found that receiving antibiotic treatments early in life can increase susceptibility to specific diseases later on.

19 Aug 2014

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.

19 Aug 2014

Globavir plans to seek approval, launch novel drug for treatment of Ebola infection

Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.

19 Aug 2014

Lilly and Boehringer Ingelheim's Basaglar (insulin glargine injection) gets FDA's tentative approval

The U.S. Food and Drug Administration today granted tentative approval for Basaglar (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes.

19 Aug 2014

Dopamine therapy linked to increased impulse control disorders, daytime sleepiness in early PD patients

New Penn Medicine research shows that neuropsychiatric symptoms such as depression, anxiety and fatigue are more common in newly diagnosed Parkinson's disease (PD) patients compared to the general population.

18 Aug 2014

Assumptions on teen sexual activity result in low rates of HPV vaccination

Probing deeper into the complex decisions that parents and providers face regarding the human papilloma virus (HPV) vaccine, researchers found that though both parties appreciated importance of the HPV vaccine, their personal assumptions surrounding timing of administration relative to onset of sexual activity resulted in decreased vaccination rates.

18 Aug 2014

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Immune Targeting Systems, specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A.

18 Aug 2014

Researchers compare benefits of bivalirudin and heparin for patients undergoing coronary stenting

Bivalirudin and heparin are two anticoagulant options for patients undergoing coronary stenting for ischemic heart disease. Bivalirudin, a newer anticoagulant, has been touted as being as effective as generic heparin, but with nearly half the rate of bleeding.

18 Aug 2014

Federal law enacted to combat use of "club drugs" fails to reduce drugs' popularity

A federal law enacted to combat the use of "club drugs" such as Ecstasy - and today's variation known as Molly - has failed to reduce the drugs' popularity and, instead, has further endangered users by hampering the use of measures to protect them.

18 Aug 2014

61% of U.S. adults unaware of the importance of high dose flu vaccine in flu prevention for older adults

A new survey from CVS/pharmacy released today found that three in five U.S. adults (61 percent) are unaware of the importance of the high dose flu vaccine in flu prevention for adults 65 years and older.

16 Aug 2014

WHO taps UTMB to lead emerging infectious disease vaccine efforts

The world experts on vaccine development at the University of Texas Medical Branch at Galveston have received an international designation acknowledging their unique niche in a sphere where research, government regulation and big pharma often collide.

16 Aug 2014

Finding suggests that aspirin could play role in reducing breast cancer mortality

Researchers have discovered that women who had been prescribed aspirin regularly before being diagnosed with breast cancer are less likely to have cancer that spread to the lymph-nodes than women who were not on prescription aspirin. These women are also less likely to die from their breast cancer.

15 Aug 2014

Pharmaceutical News

Studies support clinical use of antidepressants for treatment of postoperative pain

Perampanel does not offer added benefit for patients with Epilepsy

New therapeutic drug may prevent respiratory depression in patients taking opioid medication

Dasatinib: Leukemia drug shows promise for treating skin, breast and other cancers

Researchers shed light on the dual action of aspirin

Acetyl fentanyl is more potent and dangerous than heroin

University of Kansas researcher earns grant to study role of dietary supplement in muscle growth

Novartis and Gamida Cell sign Option and Investment Agreements

New research finds that early use of antibiotics can alter immunity later on

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

Globavir plans to seek approval, launch novel drug for treatment of Ebola infection

Lilly and Boehringer Ingelheim's Basaglar (insulin glargine injection) gets FDA's tentative approval

Dopamine therapy linked to increased impulse control disorders, daytime sleepiness in early PD patients

Assumptions on teen sexual activity result in low rates of HPV vaccination

ITS develops new T cell vaccine to protect humans from seasonal and pandemic influenza A

Researchers compare benefits of bivalirudin and heparin for patients undergoing coronary stenting

Federal law enacted to combat use of "club drugs" fails to reduce drugs' popularity

61% of U.S. adults unaware of the importance of high dose flu vaccine in flu prevention for older adults

WHO taps UTMB to lead emerging infectious disease vaccine efforts

Finding suggests that aspirin could play role in reducing breast cancer mortality

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News